Comcast Corporation (CTP2)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 20.45 |
|---|---|
| 52-week range | 18.39 – 27.61 |
| Return, 1 month / 3 months | +4.5% / −0.7% |
| Return, 1 year / 3 years | −10.7% / −39.4% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 30.7% |
| Worst drawdown (1 year) | -30.3% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 5.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Comcast Corporation is a media and communications company based in Philadelphia. It provides cable television, broadband internet and telephone services to residential and business customers, mainly under the Xfinity brand. Through NBCUniversal, it owns television networks, a film studio, theme parks and a streaming service. The company also produces and distributes news, sports and entertainment programming to audiences and advertisers around the world.
Comcast Corporation trades under the code CTP2 on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Comcast Corporation (CTP2) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 20.45 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 437 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.7% and over the last three months it fell 0.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.2% | ||
| From 52-week high | -25.8% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.7% | ||
| 6-month return | -16.0% | ||
| 12-month return, skipping the last month | -14.6% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.3% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.2% |
|---|---|
| 1 month | +4.5% |
| 3 months | −0.7% |
| 6 months | −16.0% |
| 1 year | −10.7% |
| 3 years | −39.4% |
| 5 years | −43.7% |
Signals
| 50-day / 200-day average | 20.59 / 22.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Oct 2026 | USD 0.2935 |
| 1 Jul 2026 | USD 0.2935 |
| 1 Apr 2026 | USD 0.2935 |
| 14 Jan 2026 | USD 0.2935 |
| 1 Oct 2025 | USD 0.2935 |
| 2 Jul 2025 | USD 0.2935 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.